Rhythm Pharmaceuticals Inc. (RYTM)
Market Closed
17 Jul, 20:00
$
106. 60
+0.51
+0.4807%
$
7.54B Market Cap
- P/E Ratio
- Div Yield
773,300 Volume
-4.17 Eps
$ 106.09
Previous Close Want to track RYTM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rhythm Pharmaceuticals Inc. (RYTM) Statistics
Valuation metrics
Market Cap 7.54B
Enterprise value 7.48B
Trailing P/E (ttm) -34.06
Forward P/E -
PEG ratio 2.8
Price/Sales (ttm) 33.67
Price/Book (mrq) 58.96
Enterprise Value/Revenue 34.43
Enterprise Value/EBITDA -41.37
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 760.56K
Average volume (90 days) 815.27K
Price summary
52-Week low 74.5
52-Week high 122.2
Beta -
50-Day moving average 97.97
200-Day moving average 94.55
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.93%
Operating margin -0.91%
Operational effectiveness
Return on assets -0.46%
Return on equity -2.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.19
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.98
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.01
Total debt (mrq) -
Total Debt/Equity (mrq) 1.85
Current ratio (mrq) 4.17%
Book value per share (mrq) 1.81
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
